Related by context. All words. (Click for frequent words.) 72 sunitinib malate 72 axitinib 70 CIMZIA TM 70 low dose cytarabine 70 iniparib 70 temsirolimus 69 Jevtana 69 abiraterone 69 ixabepilone 69 vandetanib 69 decitabine 69 pomalidomide 69 metastatic castration resistant 69 Torisel 69 Vandetanib 69 Velcade bortezomib 69 tocilizumab 69 FOLFIRINOX 69 regorafenib 69 APTIVUS r 68 Fludara 68 olaparib 68 azacitidine 68 Amrubicin 68 recurrent NSCLC 68 standard chemotherapy regimen 68 metastatic hormone refractory 68 Pemetrexed 68 Ixempra 68 CIMZIA ™ 68 VIDAZA 68 relapsed MM 68 mapatumumab 68 Taxotere ® 68 gemcitabine chemotherapy 68 PROMACTA 68 sorafenib Nexavar 68 elotuzumab 68 ACTEMRA TM 68 IRESSA 68 HuMax EGFr 68 lapatinib Tykerb 68 lapatinib 67 Cimzia TM 67 MAGE A3 ASCI 67 5-FU/LV 67 Targretin 67 erlotinib Tarceva 67 motesanib 67 YONDELIS 67 afatinib 67 docetaxel chemotherapy 67 HER2 positive metastatic breast 67 DOXIL 67 ZOLINZA 67 Tarceva TM 67 enzastaurin 67 neratinib 67 ACZ# 67 lenalidomide Revlimid R 67 paclitaxel Taxol R 67 Doxil ® 67 TEMODAL 67 docetaxel Taxotere 67 adalimumab Humira 67 glufosfamide 67 desvenlafaxine succinate 67 trastuzumab Herceptin 67 Phase Ib clinical 67 canakinumab 67 Asentar 67 sargramostim 67 cabazitaxel 67 trastuzumab Herceptin ® 67 Tarceva erlotinib 67 Ophena TM 66 vicriviroc 66 NATRECOR R 66 pegylated liposomal doxorubicin 66 ritonavir boosted 66 estramustine 66 Onrigin 66 Zytiga 66 Herceptin trastuzumab 66 AZILECT R 66 forodesine 66 beta 1a 66 TORISEL 66 clodronate 66 FOLFOX4 66 visilizumab 66 melphalan prednisone 66 Ceplene/IL-2 66 pemetrexed Alimta 66 SUTENT 66 gemcitabine carboplatin 66 EOquin 66 Mylotarg 66 INCB# [001] 66 fostamatinib 66 CHOP chemotherapy 66 ATL# [001] 66 TYKERB 66 Taxotere chemotherapy 66 panitumumab 66 telaprevir dosed 66 apremilast 66 alvespimycin 66 dasatinib 66 vorinostat 66 Traficet EN 66 nab paclitaxel 66 MGd 66 weekly subcutaneous injections 66 bendamustine 66 paclitaxel Taxol ® 66 Symadex 66 Pertuzumab 66 oral ridaforolimus 66 SNT MC# 66 gefitinib Iressa 66 BEXXAR 66 APTIVUS 66 Nexavar sorafenib 66 infusional 5-FU/LV 66 atrasentan 66 Campath alemtuzumab 65 relapsed refractory multiple myeloma 65 mycophenolate mofetil 65 Lapatinib 65 mitoxantrone 65 CANCIDAS 65 mg kg dose 65 GVAX 65 Dasatinib 65 Fludarabine 65 plus dexamethasone 65 pertuzumab 65 custirsen 65 azilsartan medoxomil 65 ZACTIMA 65 Hycamtin 65 romiplostim 65 Cloretazine 65 Arranon 65 Irinotecan 65 EFAPROXYN 65 PSMA ADC 65 refractory CLL 65 Amplimexon 65 thalidomide Thalomid 65 Sprycel dasatinib 65 Xcytrin 65 bevacizumab Avastin 65 registrational trial 65 sunitinib 65 ACAPODENE 65 Evoltra 65 Taxotere docetaxel 65 teriflunomide 65 BAY #-# 65 nitazoxanide 65 Xeloda capecitabine 65 non metastatic osteosarcoma 65 SPRYCEL ® 65 sustained virologic response 65 DAPT 65 Xelox 65 Bezielle 65 zoledronic acid 65 HGS# 65 Revlimid lenalidomide 65 baminercept 65 MabCampath 65 ofatumumab 65 receptor tyrosine kinase inhibitor 65 recurrent glioblastoma multiforme 65 PXD# 65 rilonacept 65 safinamide 65 lenalidomide dexamethasone 65 ruxolitinib 65 romidepsin 65 doxorubicin docetaxel 65 leukemia AML 65 phase IIb trial 65 FOLFIRI 65 FIRMAGON 65 FAMPYRA 65 cilengitide 65 FOLPI 65 INC# 65 lenalidomide Revlimid 65 etravirine 65 relapsed ovarian cancer 65 amrubicin 65 Dacogen injection 65 PDE4 inhibitor 65 Flu Cy 65 Raptiva ® 65 fluvastatin 65 Platinol ® 65 RAPAFLO 65 Laquinimod 65 tesmilifene 65 Erbitux cetuximab 65 concurrent chemoradiation 65 5 Fluorouracil 64 pramipexole 64 YERVOY 64 cangrelor 64 interferon alfa 64 eribulin mesylate 64 mitoxantrone plus 64 Troxatyl 64 comparator arm 64 tamoxifen therapy 64 Targretin capsules 64 Glufosfamide 64 lumiliximab 64 chlorambucil 64 placebo controlled clinical 64 lintuzumab 64 heavily pretreated 64 velafermin 64 Roche Xeloda 64 Golimumab 64 eltrombopag 64 plus prednisone 64 tipranavir 64 Abiraterone acetate 64 vemurafenib 64 sorafenib tablets 64 refractory AML 64 vidofludimus 64 paclitaxel Taxol 64 NOXAFIL 64 efalizumab 64 relapsed multiple myeloma 64 Epratuzumab 64 neoadjuvant treatment 64 GAMMAGARD 64 Erlotinib 64 bortezomib 64 erlotinib Tarceva ® 64 Gleevec imatinib 64 VAPRISOL 64 Temsirolimus 64 pegylated interferon alpha 64 urocortin 2 64 TYGACIL 64 carboplatin paclitaxel 64 abatacept 64 trastuzumab Herceptin R 64 pancreatic neuroendocrine tumors 64 ibandronate 64 REVLIMID ® 64 AVASTIN 64 Vidaza azacitidine 64 pitavastatin 64 docetaxel Taxotere R 64 ONTAK 64 vinorelbine 64 Sandostatin LAR Depot 64 goserelin 64 Phase Ib II 64 registrational 64 relapsing multiple sclerosis 64 lomitapide 64 diabetic neuropathic pain 64 Cloretazine ® 64 STELARA 64 Halaven 64 RoACTEMRA 64 Zolinza 64 REMINYL ® 64 LIALDA 64 paclitaxel poliglumex 64 alvimopan 64 daclizumab 64 Insegia 64 oblimersen 64 Xanafide 64 REMICADE ® 64 postoperative chemotherapy 64 untreated multiple myeloma 64 Gabapentin GR 64 riociguat 64 PREZISTA r 64 LAF# 64 Navelbine ® 64 Aflibercept 64 adalimumab 64 Lialda 64 ELACYT 64 metastatic castrate resistant 64 Triapine 64 CHARM Added 64 sorafenib 64 atacicept 64 Mitoxantrone 64 metastatic renal cell carcinoma 64 Pirfenidone 64 Taxol paclitaxel 64 cinacalcet 64 zalutumumab 64 odanacatib 64 dasatinib Sprycel ® 64 KRAS status 64 DEB# 64 IRX 2 64 dacetuzumab 64 prednisone prednisolone 64 Yervoy 64 anti leukemic 64 intravenous bisphosphonates 64 pain palliation 64 oral FTY# 64 Dendreon Provenge 64 TroVax ® 64 ganetespib 64 levosimendan 64 Xinlay 64 fenofibric acid 64 IGF 1R inhibitor 64 severe hypercholesterolemia 64 Femara letrozole 64 Ocrelizumab 64 cetuximab Erbitux 64 Gefitinib 64 nilotinib 63 vismodegib 63 Phenoptin 63 olmesartan 63 neurologic progression 63 Bronchitol 63 CAELYX 63 Degarelix 63 AGILECT ® 63 bosutinib 63 STRIDE PD 63 Capesaris 63 AEGR 63 Avastin bevacizumab 63 briakinumab 63 SIMPONI 63 talabostat 63 bicalutamide 63 Zyclara 63 huN# DM1 63 #mg/m# [001] 63 FROVA 63 tafamidis 63 Ceflatonin 63 Plenaxis TM 63 Rituxan rituximab 63 Oxaliplatin 63 Omnitarg 63 mRCC 63 ARIMIDEX 63 Elitek 63 ELND# 63 ELOXATIN 63 mTOR inhibitor 63 genotypic resistance 63 MYCAMINE 63 PROSTVAC ® 63 RAPTIVA 63 protease inhibitor PI 63 TAXOTERE R 63 plus prednisone prednisolone 63 CA4P 63 PSN# [002] 63 adjuvant endocrine therapy 63 depsipeptide 63 gemcitabine cisplatin 63 peginterferon 63 tipranavir r 63 sunitinib Sutent 63 corticosteroid dexamethasone 63 oral deforolimus 63 CHAMPION PCI 63 Aplidin 63 FTY# 63 liposomal doxorubicin 63 Zemplar 63 Tesmilifene 63 ISENTRESS 63 brivaracetam 63 nucleoside analog 63 FOR FURTHER INFORMATION ABOUT 63 aflibercept 63 Vectibix monotherapy 63 Neoadjuvant 63 Pegintron 63 pazopanib 63 Dyloject TM 63 docetaxel Taxotere ® 63 INCB# [003] 63 flutamide 63 eosinophilic asthma 63 oral rivaroxaban 63 ATACAND 63 CoFactor 63 lesinurad 63 icatibant 63 posaconazole 63 OvaRex MAb 63 mCRC patients 63 INTELENCE 63 therapeutic regimens 63 NVA# 63 COPAXONE R 63 paliperidone ER 63 VELCADE melphalan 63 dacarbazine 63 Phase IIIb clinical 63 novel oral anticoagulant 63 tolterodine 63 ARCOXIA 63 dosing cohort 63 blinded randomized placebo controlled 63 Marqibo 63 Vectibix panitumumab 63 Doxil 63 valopicitabine 63 Neuvenge 63 Quinamed 63 mifamurtide 63 acyclovir Lauriad R 63 Arikace 63 dose cohort 63 teduglutide 63 Topotecan 63 Gemcitabine 63 cisplatin chemotherapy 63 Cytoxan 63 Lenalidomide 63 RRMS patients 63 Zemplar Capsules 63 Pazopanib 63 Gleevec Glivec 63 galiximab 63 INTEGRILIN 63 pediatric malignancies 63 rosuvastatin #mg 63 AGILECT R 63 Cetuximab 63 cediranib 63 BRIM2 63 interferon therapy 63 tanespimycin 63 Zarnestra 63 #mg dose [001] 63 pramlintide 63 phase IIa clinical 63 Afatinib 63 cytotoxic therapy 63 refractory metastatic 63 Saforis 63 glatiramer acetate 63 FOLFOX regimen 63 boosted protease inhibitor 63 Xeloda ® 63 peg interferon 63 Blinatumomab 63 fluoropyrimidine 63 IMGN# 63 Octreolin 63 DU #b 63 Alvesco R 63 FOLFOX6 63 SUTENT ® 63 peginterferon alfa 2a 63 XELOX 63 Betaferon R 63 Phase 2a trial 63 metastatic CRC 63 raloxifene Evista 63 QNEXA 63 Azedra 63 rapid virologic response 63 irbesartan 63 IFN beta 63 alfa 2a 63 dosing intervals 63 raltegravir 63 Phase IIa trials 63 randomized Phase IIb 63 TroVax 63 SEROQUEL XR 63 adenoma recurrence 63 temozolomide 63 Talabostat 63 Alkeran 63 Sutent sunitinib 63 gastrointestinal stromal tumors GIST 63 GW# [003] 63 5FU 63 chemoradiation therapy 63 Ozarelix 63 Virulizin ® 63 dose escalation phase 63 gefitinib 63 Folfox 63 eribulin 63 squamous histology 63 ULORIC 63 oral chemotherapeutic agent 63 recurrent GBM 63 Prostate AdenoCarcinoma Treatment 63 Sorafenib 62 Hydroxyurea 62 figitumumab 62 Neurodex 62 mertansine 62 allogeneic SCT 62 PEG SN# 62 phase IIb clinical 62 GnRH agonists 62 Fludara ® 62 Peg IFN 62 Cloretazine R VNP#M 62 IMC A# 62 Allovectin 7 ® 62 Provecta 62 APTIVUS ritonavir 62 ribavirin RBV 62 inhaled cyclosporine 62 albinterferon alfa 2b 62 PROSTVAC VF 62 fluorouracil 62 ToGA 62 Hormone Refractory Prostate Cancer 62 Neupogen ® 62 Trastuzumab 62 Phase Ib study 62 iniparib BSI 62 certolizumab 62 adecatumumab 62 PARP inhibitor 62 Telintra 62 QVA# 62 trastuzumab 62 CAPHOSOL 62 HuLuc# 62 unresectable stage 62 bortezomib Velcade R 62 COPAXONE ® 62 biologic DMARD 62 Genasense 62 achieved ACR# 62 nucleotide analogue 62 Vicinium TM 62 aprepitant 62 Noxafil 62 Eltrombopag 62 plus gemcitabine 62 placebo dexamethasone 62 placebo controlled clinical trials 62 Melphalan 62 AMEVIVE 62 RSD# 62 alicaforsen enema 62 Boceprevir 62 obatoclax 62 OvaRex ® MAb 62 phase IIb study 62 docetaxel 62 TYSABRI natalizumab 62 Pegasys peginterferon alfa 2a 62 degarelix 62 uric acid lowering 62 Aryplase 62 Emselex 62 Tanespimycin 62 Sanofi Aventis Taxotere 62 oral prodrug 62 anastrozole 62 Raptiva R 62 RhuDex R 62 LYSTEDA 62 LY# [003] 62 CIMZIA TM certolizumab pegol 62 anti androgen 62 peg IFN 62 treprostinil 62 Platinol ® cisplatin 62 demonstrated antitumor activity 62 XmAb# 62 anthracycline taxane 62 advanced hepatocellular carcinoma 62 pradefovir 62 vinflunine 62 Archexin 62 lasofoxifene 62 alemtuzumab Campath 62 VIMOVO 62 metastatic RCC 62 Saxagliptin 62 rasagiline tablets 62 gemcitabine Gemzar 62 deforolimus 62 DCCR 62 Onconase 62 MAS XR 62 CAMPATH 62 trastuzumab DM1 T DM1 62 letrozole Femara 62 elvitegravir 62 divalproex sodium 62 oxymorphone ER 62 alefacept 62 urate lowering 62 JAK inhibitor 62 talactoferrin 62 TRISENOX 62 ritonavir boosted lopinavir 62 oral anticancer 62 alemtuzumab treated 62 AeroLEF TM 62 Panzem R NCD 62 PegIntron 62 gemifloxacin 62 palifermin 62 oral salmon calcitonin 62 ISTODAX 62 interferon gamma 1b 62 rindopepimut 62 Neulasta ® 62 Carfilzomib 62 randomized Phase 2b 62 ximelagatran 62 OHR/AVR# 62 Onco TCS 62 orBec 62 Fingolimod 62 AZT zidovudine Retrovir 62 XGEVA 62 Exemestane 62 HDAC Inhibitor 62 Reverset 62 Fulvestrant 62 CLL SLL 62 metaglidasen 62 Seliciclib 62 Betaferon ® 62 cisplatin vinorelbine 62 SCH # 62 marketed pegylated interferons 62 ara C 62 LHRH agonists 62 sapacitabine 62 docetaxel prednisone 62 CLARITY study 62 Triapine R 62 OMAPRO 62 venlafaxine ER 62 AZILECT ® 62 capecitabine Xeloda 62 dasatinib Sprycel 62 Gattex 62 ProSavin 62 TELINTRA 62 BEXXAR Therapeutic Regimen 62 Tolvaptan 62 relapsed SCLC 62 PEGylated interferon beta 1a 62 imatinib mesylate Gleevec 62 metastatic renal cell 62 lupus nephritis 62 OPAXIO 62 Clonicel 62 relapsed refractory 62 EndoTAG TM -1 62 rituximab Rituxan ® 62 Vaprisol 62 GRN# 62 AGGRASTAT ® 62 Taxotere R 62 panitumumab Vectibix 62 Stelara 62 Mepact 62 APTIVUS R 62 Bosutinib 62 MVax 62 Sanctura XR 62 cell lymphoma CTCL 62 antibody MAb 62 Fibrillex TM 62 Mipomersen 62 immunomodulatory therapy 62 phase Ib 62 PegIFN RBV 62 Catena ® 62 Tasimelteon 62 ARIXTRA R 62 Gleevec imatinib mesylate 62 anthracyclines taxanes 62 chemoradiotherapy 62 CCX# 62 darunavir 62 Allovectin 7 62 Cimzia ® certolizumab pegol 62 lymphoid malignancies 62 taxane chemotherapy 62 pamidronate 62 atazanavir sulfate 62 trospium 62 Omacetaxine 62 nonmetastatic prostate cancer 62 refractory chronic lymphocytic 62 Dapagliflozin 62 ruboxistaurin 62 cinacalcet HCl 62 Viramidine 62 Tavocept 62 R#/MEM # 62 Raptiva r 62 micafungin 62 Platinol 62 Zybrestat 62 Dabigatran etexilate 62 preoperative chemotherapy 62 CTAP# Capsules 62 zileuton 62 Phase IIb trials 62 lixisenatide 62 LymphoStat B belimumab 62 insulin detemir 62 pegylated interferons 62 salmeterol fluticasone 62 plus DOXIL 62 TREANDA 62 SCCHN 62 PF # [002] 62 ASCT 62 HGS ETR1 62 ACOMPLIA R 62 IMA# 62 6R BH4 62 Zorbtive TM 62 elagolix 62 Focalin XR 62 midstage clinical 62 Rezular 62 tramiprosate Alzhemed TM 62 androgen deprivation 62 Alocrest 62 ASA# 62 Xyotax 62 imatinib Gleevec ® 62 PRADAXA 62 prostate cancer CRPC 62 CCX# B 62 pegylated interferon alfa 2b 62 rufinamide 62 Roche Actemra 62 TAXOTERE ® 62 ORENCIA ® 62 dexpramipexole 61 oral Hycamtin 61 indolent NHL 61 Vilazodone 61 THALOMID 61 celgosivir 61 Silodosin 61 Vitaxin 61 Phase IIb clinical trials 61 dosage regimens 61 8mg/kg 61 Genz # 61 #mg BID [001] 61 MyVax R 61 pemetrexed 61 CR# vcMMAE 61 Decitabine 61 tipifarnib 61 Bayer Onyx 61 E1 INT TM 61 evaluating tivozanib 61 ARB telmisartan 61 Q#IR 61 LEUKINE 61 5 FU 61 colesevelam HCl 61 IFN α 61 Orazol 61 IIa trial 61 PEG INTRON 61 desvenlafaxine 61 doxorubicin cyclophosphamide 61 TACI Ig 61 Proellex TM 61 octreotide LAR 61 adjuvant tamoxifen 61 Amigal 61 CsA 61 MERLIN TIMI 61 stage IIIb IV 61 aflibercept VEGF Trap 61 farletuzumab 61 Cotara 61 lipid lowering therapy 61 HRPC 61 pegylated interferon alfa 61 paricalcitol 61 ARG# 61 Proxinium TM 61 REYATAZ R 61 chemotherapeutic regimen 61 Toremifene 61 Tyrima 61 CBLC# 61 favorable pharmacokinetic profile 61 Aloxi injection 61 terlipressin 61 Triolex 61 5-fluorouracil/leucovorin 61 liprotamase 61 insulin glulisine 61 HoFH 61 histone deacetylase HDAC inhibitor 61 etanercept 61 Actilon 61 Imprime PGG 61 CCR5 antagonist 61 Zenvia ™ 61 Proquin XR 61 Cimzia R 61 NLX P# 61 imexon 61 Phase IIa trial 61 EDARBI 61 ZD# [001] 61 rivaroxaban 61 Northera 61 EQUETRO 61 Gemzar ® 61 imatinib Gleevec 61 GLIADEL R Wafer 61 CRLX# 61 ImClone Erbitux 61 Aptivus ® 61 tenofovir emtricitabine 61 erlotinib 61 FOLFOX 61 ponatinib 61 Bevacizumab 61 rFIXFc 61 recurrent ovarian cancer 61 interferon ribavirin 61 topotecan 61 methylnaltrexone 61 Panzem R 61 VNP#M 61 secondary efficacy endpoints 61 Febuxostat 61 GAMMAGARD LIQUID 61 ropinirole 61 concomitant medications 61 Phase IIB 61 Onbrez Breezhaler 61 MDV# 61 SILENOR 61 Aptivus 61 octreotide implant 61 TMC# [002] 61 phase IIIb 61 relapsed myeloma 61 standard chemotherapy regimens 61 rituximab Rituxan 61 Fablyn 61 eniluracil 61 ranolazine 61 Pimavanserin 61 MEK inhibitors 61 TNF antagonist 61 KRAS mutations occur 61 Ambrisentan 61 superficial bladder cancer 61 ALGRX 61 FluCAM 61 Hsp# Inhibitor 61 CEQ# 61 OncoVEX GM CSF 61 atazanavir ritonavir 61 samalizumab 61 L BLP# 61 elacytarabine 61 ancrod 61 refractory CTCL 61 TG# [003] 61 TMC# [001] 61 Natalizumab 61 TMC# r 61 RSR# 61 idarubicin 61 sipuleucel T 61 #I TM# 61 indiplon capsules 61 ARIXTRA 61 Interferon alpha 61 HGS ETR2 61 Faslodex 61 pregabalin 61 MIRCERA 61 epirubicin 61 hA# 61 Renal Cell Carcinoma RCC 61 Phase #/#a trial 61 mecamylamine 61 calcineurin inhibitor 61 Azacitidine 61 mesalamine granules 61 Teriflunomide 61 antioxidant supplementation 61 Promacta 61 Severe Sepsis 61 Votrient 61 surrogate endpoint 61 ASONEP 61 primary hypercholesterolemia 61 IMiDs 61 Remicade infliximab 61 Advagraf 61 CLL8 61 R# #mg BID 61 BR.# 61 efficacy endpoint 61 SCIg 61 HuMax CD4 61 Oral corticosteroids 61 Pivotal Phase III 61 tarenflurbil 61 castration resistant prostate cancer 61 castrate resistant prostate cancer 61 recurrent glioblastoma 61 adjuvant radiotherapy 61 ER CHOP 61 dirucotide 61 aldosterone antagonists 61 bortezomib Velcade 61 GnRH antagonist 61 balsalazide tablet 61 fluticasone salmeterol 61 Urocidin 61 efaproxiral 61 Phase Ib 61 febuxostat 61 Daclizumab 61 PROSTVAC TM 61 Simulect 61 HQK 61 Durezol 61 idraparinux 61 PEGINTRON TM 61 Phase 1b trial 61 ADVANCE PD 61 herpetic keratitis 61 Paraplatin ® 61 follicular lymphoma FL 61 PRT# 61 methotrexate monotherapy 61 ADAGIO study 61 tapentadol ER 61 miglustat 61 mg/m2 dose 61 trabectedin 61 advanced metastatic prostate 61 intermittent dosing 61 Tocosol Paclitaxel 61 multiple myeloma MM 61 Merck KGaA Erbitux 61 fulvestrant 61 IMC #B 61 refractory multiple myeloma 61 BCR ABL inhibitor 61 BRIM3 61 mycophenolate mofetil MMF 61 oral clodronate 61 Thalomid ® 61 mg BID 61 LT NS# 61 cytoreductive nephrectomy 61 EndoTAGTM 1 61 trabedersen 61 relapsed CLL 61 BEXXAR therapeutic regimen 61 Nexavar ® 61 dextromethorphan quinidine 61 BENICAR HCT 61 liposomal formulation 61 NovoTTF 61 evaluating REVLIMID 61 eritoran 61 paliperidone palmitate 61 crizotinib PF # 61 VEGF inhibitor